The use of artificial intelligence (AI) tools, spearheaded by generative AI, is expanding into various spheres of society, including the labour market. A study conducted by the Universitat Oberta de… read more.
As artificial intelligence (AI) becomes more common in health care, from managing records to assisting with medication decisions, researchers at the Icahn School of Medicine at Mount Sinai… read more.
Vertex Pharmaceuticals Incorporated announced data from a Phase IV study of Journavx (suzetrigine), a prescription non-opioid pain signal inhibitor for the treatment of moderate-to-severe acute pain, in adults,… read more.
Animal welfare is gaining increasing global attention, but what it means to ensure a “good life” for animals can vary across cultures. The World Organisation for Animal Health… read more.
Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British… read more.
GE HealthCare announced that View has received 510(k) clearance from the FDA. Designed as a fast, diagnostic, zero‑footprint viewer, View serves as the core anchor of the Genesis… read more.
Premature ovarian insufficiency (POI) is a clinically significant cause of infertility that affects between 1 to 3% of women of childbearing age. Symptoms include absent menses, low estrogen… read more.
A simple 5-minute test addressing major endometriosis diagnostic delays and treatment, has been developed by University of Queensland researchers. The Simplified Adolescent Factors for Endometriosis (SAFE) score uses… read more.
Ardelyx Inc. announced the publication of data from its IBS-C clinical development program, “Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis”… read more.
High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease and stroke. For decades, researchers have observed that premenopausal women are less likely to develop high blood pressure than men or postmenopausal… read more.
Tenpoint Therapeutics, Ltd., announced that the FDA approved Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as Brimochol PF, the first and only dual-agent eye drop… read more.
Washington State University researchers have developed a 3D-printed model of the left side of the heart that contracts and beats, offering the chance for surgeons and medical students… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
